subject area of
- ATM and CDK2 control chromatin remodeler CSB to inhibit RIF1 in DSB repair pathway choice Academic Article
- Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer? Academic Article
- CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection Academic Article
- Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial Academic Article
- Cockayne Syndrome group B protein interacts with TRF2 and regulates telomere length and stability Academic Article
-
Cockayne syndrome group B protein regulates
DNA double‐strand break repair and checkpoint activation Academic Article - Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells Academic Article
- Cockayne syndrome group B protein uses its DNA translocase activity to promote mitotic DNA synthesis Academic Article
- Early host cell reactivation of an oxidatively damaged adenovirus-encoded reporter gene requires the Cockayne syndrome proteins CSA and CSB Academic Article
- Efficient UV repair requires disengagement of the CSB winged helix domain from the CSB ATPase domain Academic Article
- HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy Academic Article
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data Academic Article
- Predicting Anthracycline Benefit: TOP2A and CEP17—Not Only but Also Academic Article
- TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients Academic Article
- The Winged Helix Domain of CSB Regulates RNAPII Occupancy at Promoter Proximal Pause Sites Academic Article
- Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy Academic Article
- Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial Academic Article